LYSOBACTIN FOR USE IN TREATMENT OF BOVINE MASTITIS Russian patent published in 2021 - IPC A61K38/15 A61P29/00 A61P31/04 C07K7/56 

Abstract RU 2741764 C2

FIELD: pharmaceuticals.

SUBSTANCE: invention relates to use of lysobactin for treating bacterial bovine mastitis. Lysobactin is administered intramammary in dose of 25 to 1,000 mg per quarter of udder. Invention also relates to a pharmaceutical composition for treating bacterial bovine mastitis formulated for intramammary introduction into cow mammary glands, containing lysobactin and a pharmaceutically acceptable excipient.

EFFECT: declared intramammary administration of lysobactin in dosage of 25 to 1,000 mg per quarter of udder is effective and safe in udder medium, including lactating cows, and results in fast and prolonged effect.

8 cl, 5 dwg, 8 ex

Similar patents RU2741764C2

Title Year Author Number
COMBINATIONS OF LYSOBACTIN AND AMINOGLYCOSIDES AGAINST DISEASES CAUSED BY GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA IN NON-HUMAN ANIMALS 2018
  • Shiffer, Guido
  • Felker, Shtefan
  • Daube, Gert
  • Vil, Volfgang
  • Kebberling, Jokhannes
RU2760008C2
METHODS OF TREATING MICROBIAL INFECTIONS, INCLUDING MASTITIS 2014
  • Pejdzh Stefen
  • Garg Sandzhaj
RU2662300C2
PHARMACEUTICAL COMPOSITIONS AND METHOD OF TREATING MASTITES 2013
  • Frojman Robrekht
  • Vettsshtajn Khajnts-Georg
  • Fratts Kristine
  • Vil Volfgang
RU2659430C2
METHOD FOR PRODUCING SUSPENSION-EMULSION OF PRIMYCIN 0
  • Anna Z.Sabo
  • Jozhef Gaal
  • Katalin Marmoroshi
  • Dyula Shebeshen
  • Gizella Mikholich
  • Marta Kovach
SU1837870A3
COMPOSITIONS AND METHOD OF CONTROLLING INFECTIONS IN NON-HUMAN MAMMALS USING ACUTE PHASE PROTEINS 2014
  • Bach Arisa Alekhandro
  • Pares Silviya
  • Domenech Anna
  • Aris Anna
RU2725841C2
STRAIN OF BACTERIA STREPTOCOCCUS DYSGALACTIAE FOR MAKING BIOPREPARATIONS FOR SPECIFIC PREVENTION OF MASTITIS IN COWS 2023
  • Evgrafova Valeriia Adreevna
  • Briantseva Mariia Sergeevna
  • Pruntova Olga Vladislavovna
  • Shadrova Natalia Borisovna
  • Ruchnova Olga Ivanovna
  • Andreeva Anna Andreevna:
  • Voronina Margarita Sergeevna
RU2818361C1
APPLICATION OF PULSATILLA CHINENSIS EXTRACT FOR OBTAINING A DRUG FOR THE TREATMENT OF VIRAL AND/OR BACTERIAL DISEASES 2019
  • Yan, Shilin
  • Su, Chzhetun
RU2799050C2
SA-21 STRAIN OF BACTERIA OF STREPTOCOCCUS GENUS OF STREPTOCOCCUS AGALACTIAE SPECIES FOR THE MANUFACTURE OF BIOLOGICAL PRODUCTS FOR THE SPECIFIC PREVENTION OF MASTITIS IN COWS 2022
  • Evgrafova Valeriya Andreevna
  • Bryantseva Mariya Sergeevna
  • Biryuchenkov Dmitrij Anatolevich
  • Byadovskaya Olga Petrovna
  • Gubenko Olesya Grigorevna
  • Bukhon Elena Aleksandrovna
  • Ruchnova Olga Ivanovna
RU2799603C1
USE OF A SYMBIOTIC CONSORTIUM OF PROBIOTIC LACTOBACILLI STRAINS ISOLATED FROM HUMAN MILK, WHICH HAS A BACTERICIDAL EFFECT ON MASTITIS-INDUCING PATHOGENS, FOR THE MANUFACTURE OF DRUGS FOR THE COMPLEX PREVENTION AND TREATMENT OF LACTATIONAL MASTITIS 2022
  • Priputnevich Tatyana Valerevna
  • Gordeev Aleksej Borisovich
  • Shabanova Natalya Evgenevna
  • Muraveva Vera Vasilevna
  • Nikolaeva Anastasiya Vladimirovna
  • Sukhikh Gennadij Tikhonovich
  • Abramov Vyacheslav Mikhajlovich
  • Kosarev Igor Vasilevich
  • Khlebnikov Valentin Sergeevich
  • Pchelintsev Sergej Yurevich
  • Sakulin Vadim Konstantinovich
  • Vasilenko Raisa Nikolaevna
  • Machulin Andrej Valerievich
RU2801119C1
IMMUNOLOGICALLY RELEVANT PROTEIN STREPTOCOCCUS 2008
  • Khil'Da Ehlizabet Smit
RU2518315C2

RU 2 741 764 C2

Authors

Shiffer Guido

Felker Shtefan

Daube Gert

Fraatts Kristine

Vil Volfgang

Kebberling Jokhannes

Dates

2021-01-28Published

2016-08-16Filed